A survival method to estimate the time to occurrence of mutations: an application to thymidine analogue mutations in HIV-1-infected patients.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D000465:Algorithms; D019380:Anti-HIV Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016679:Genome, Viral; D005838:Genotype; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics; D016013:Likelihood Functions; D009154:Mutation / Q000235:genetics*; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D016019:Survival Analysis; D013936:Thymidine / Q000031:analogs & derivatives* / Q000235:genetics*; D013997:Time Factors
D019380:Anti-HIV Agents; D013936:Thymidine